Sat.Jan 29, 2022 - Fri.Feb 04, 2022

article thumbnail

How agencies can help pharma DTC

World of DTC Marketing

The way people make treatment decisions is changing because of COVID. Agencies are responsible for working with clients to implement changes that support brand objectives. It won’t be easy and means changing the mindset from a vendor to a strategic partner. If you work in an agency, your job is not to develop a website or TV spot. You need to work with pharma clients to educate them on the complicated path from awareness to requesting an Rx.

Pharma 247
article thumbnail

Episode 78 – Paying It Forward in MedTech with Marissa Fayer, Founder of HERhealthEQ

Medical Device Success

Reading time: 2 – 4 minutes. What percentage of death due to cervical cancer are in 3 rd and 2 nd world countries? You will be shocked by the answer. It is inexcusable considering how simple the test is to detect it. HERhealthEQ is a non-profit organization that is a little different than what you may consider the typical medically related non-profit looks like.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Encouragement to Keep Going

New to Medical Device Sales

You can listen here: [link] You can watch here: [link] This was a quick episode of encouragement to keep going. The journey to break into medical device sales is a roller coaster. One day you’re at the top finding out you got the interview, just to be crushed a few days later saying that they went with an internal candidate. It can be a tough road, but I promise if you stay with it and work hard you will break in.

Sales 130
article thumbnail

A more sustainable future for all: Introducing the UN Sustainable Development Goals in InCites

Clarivate

Introducing new functionality within InCites Benchmarking and Analytics, allowing users to search and evaluate according to the UN Sustainable Development Goals. Designed in 2015 to be a “blueprint to achieve a better and more sustainable future for all,” the United Nations’ Sustainable Development Goals (SDGs) have caught the attention and the imagination of the research community.

Ethics 98
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Is it too late for Biogen?

World of DTC Marketing

Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. But is it too late for Biogen to stage a comeback with their reputation damaged? Biogen executives vowed to fight hard to reverse Medicare’s preliminary decision to sharply limit coverage of the company’s Alzheimer’s drug while saying more

article thumbnail

Insurance Underwriting Analytics | Prognos Health

Prognos Health

Anyone who has purchased groceries or filled up at a gas station recently has felt the pinch of rising costs. The current inflation rate of 6.2% is a 30-year high, and if history is any indication, healthcare costs will be among the most impacted areas going forward.

More Trending

article thumbnail

Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients

Clarify Health

Pfizer partnered with Clarify on an observational study on diagnostic testing patterns in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. This novel study is the first of its kind for ATTR-CM patients. In January 2022, the study titled, Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population, was published in the American Journal of Cardiology.

article thumbnail

A perfect storm for biotech stocks

World of DTC Marketing

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. Can small biotech companies survive? Many large pharmaceutical companies reported record performances in 2021, whether that’s a decade-high stock price or shares that outperformed the broader market as investors continued to pour money into companies maki

article thumbnail

AI-driven risk prediction: A powerful underwriting tool in an era of high inflation

Prognos Health

Anyone who has purchased groceries or filled up at a gas station recently has felt the pinch of rising costs. The current inflation rate of 6.2% is a 30-year high, and if history is any indication, healthcare costs will be among the most impacted areas going forward. According to the US Bureau of Labor Statistics, the Consumer Price Index increased 107% between December 1989 and December 2020, but the increase in healthcare costs was much more significant.

article thumbnail

Why Use a Directory for Medical Sales in Nova Scotia?

Scott’s Directories

A List Of Doctors In Nova Scotia is a sure way to find potential clients for sales in the healthcare market. The information that is provided includes contact information, location, type of physician, school history, years of being in practice, and more. This information can assist a business in understanding their role in the healthcare industry and if their product will be beneficial to the medical professional.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients

Clarify Health

Pfizer partnered with Clarify on an observational study on diagnostic testing patterns in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. This novel study is the first of its kind for ATTR-CM patients. In January 2022, the study titled, Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population, was published [.].

article thumbnail

New Report: Launch Readiness 2022 - How to address key trends and challenges

Tribeca Knowledge

I n our new report Launch Readiness 2022 , we consider how launch strategists may best navigate a fast-changing yet still commercially ripe environment for pharmaceutical launch readiness. We show how digital transformation and cutting-edge launch management software help companies track the status of launch activities and manage global launch challenges, in real-time and across both functions and countries.

article thumbnail

Therapy Launch Planning | Prognos Health

Prognos Health

Wall Street expectations and enthusiasm have been high surrounding the biotechnology and pharmaceutical sectors in recent years with investors eager to profit from the next big blockbuster therapies. However, a recent report from L.E.K. Consulting shows a considerable percentage of new drug launches have underperformed initial estimates.

article thumbnail

A matter of access

Star OUTiCO

Joanne Irving, Head of Market Access and Service Redesign, Star OUTiCO. My career started as an RGN, and I continue to work in the NHS in renal medicine. I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up Key Account Management at Boehringer-Ingelheim.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

Planning an M&A deal? Don’t overlook IP assurance.

Clarivate

In the rush to close M&A transactions, organizations can risk loss of IP value or even IP rights. Read to find out more about these IP risks. Global merger and acquisition (M&A) activity set new records in 2021, as volumes reached $5.8 trillion—a 64% increase over the previous year. [1] While M&A transactions have become a cornerstone of corporate growth strategies, they can be disruptive to the intellectual property (IP) portfolios of the companies involved.

article thumbnail

Case Study: Filming Patient Stories at Scale

Storyvine

Problem: Times have changed. In this new era of personalized medicine, influencer marketing, and customer authenticity, Pharma companies need to put real patient stories at the core of their communication and marketing strategies. But as one pharma marketer recently said to us, “It's not sustainable for me to spend $100K for one two-minute patient testimonial video.

article thumbnail

Prevent drug launch failure with an end-to-end RWD solution

Prognos Health

Wall Street expectations and enthusiasm have been high surrounding the biotechnology and pharmaceutical sectors in recent years with investors eager to profit from the next big blockbuster therapies. However, a recent report from L.E.K. Consulting shows a considerable percentage of new drug launches have underperformed initial estimates. According to the report: Nearly half the drugs launched in the past 15 years underperformed analyst estimates by more than 20% Only one-fifth of new medications

article thumbnail

Is Your Sales Content Filler or Fabulous? Why All Content Should Count

Modus

Do you have a problem with your sales content? If your organization is typical, your sales reps use only a measly 35% of the marketing content that you create. Ouch !

Sales 52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

3 KNOW-HOWS FOR BECOMING A GOOD MEDICAL SALES REPRESENTATIVE

eMediWrite

You’ll be the vital link between medical and pharmaceutical firms and healthcare providers as a Medical Sales Representative. General practitioners (GPs), hospital doctors, pharmacists, practise managers, nurses, dentists, and veterinary surgeons are just a few of the people you’ll meet. You’ll position and differentiate your items – which might include prescription pharmaceuticals, drugstore or OTC brands, wound care, nutrition, diagnostics, or vaccines – from the

article thumbnail

Monthly Employee Portal Updates | January 2022

Progressive Medical

You must be a registered user to view this information. The post Monthly Employee Portal Updates | January 2022 appeared first on Progressive Medical, Inc.

Medical 40
article thumbnail

6 Essential Constituents Of A Successful Medical Device Manufacturer And Distributor Business Partnership

Cesare Ferrari

If you are working in the commercial organization of a medical device producer, one of your objectives is to establish and maintain a successful partnership manufacturer- distributor. . An example of a good practice is when the manufacturer and distributor regularly examine their business relationships to determine if they are providing each other with the appropriate results, incentives, and support in order to strengthen their working relationships.

article thumbnail

Fatique and frustration over COVID

World of DTC Marketing

The latest KFF COVID-19 Monitor finds that fatigue and frustration dominate the public’s mood as the U.S. nears the pandemic’s second anniversary. While partisans have often been split in their pandemic attitudes, roughly three in four Democrats, independents, and Republicans say they feel “tired” and “frustrated,” and similar shares say they think it is likely that most people in the U.S. will eventually get infected with COVID-19.

Pharma 218
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.